Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on August 18, 2025
WavePoint Showcases Radar-Powered Gunshot Detection at National Homeland Security Conference
Radar-based system delivers unrivaled accuracy, zero false alarms, and faster threat response for public safety teams. WavePoint Solutions LLC Logo WASHINGTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- WavePoint Solutions, the company redefining public safety with …
Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca (IL), United States, August 18th, 2025 – Biocartis Group of Companies (“Biocartis”), an innovative molecular …
MKS Inc. to Participate in Deutsche Bank Technology Conference
ANDOVER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that John T.C. Lee, President and Chief Executive Officer, will participate in a fireside chat …
Digital Culture Group Wins the 2025 Digiday Technology Awards “Best AI Tool” for Game-Changing ARI Platform
ATLANTA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Digital Culture Group (DCG), the award-winning ad tech innovator redefining how advertisers and agencies engage modern audiences, has been awarded the 2025 Digiday Technology Awards for its proprietary AI platform …
Electrify Expo Announces First Ever Industry Day in New York on October 17 with Impressive Speaker Lineup Including Lucid, Ford, Kia, GM, BMW, Michelin and many more
Industry Day is a one-day only event designed exclusively for media, influencers, content creators, EV executives and government officials to experience the latest in electrification Tickets can be purchased online for $99 for a Friday-only pass and $125 …
Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
First-in-human trial of Capricor’s StealthX™ vaccine initiated under HHS’s Project NextGen Trial conducted and funded by the National Institute of Allergy and Infectious Diseases (NIAID) SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics ( …
BNC Expands Holdings to 325,000 BNB, Cementing Its Role as the World’s Largest BNB Treasury
New York, Monday, Aug. 18, 2025 (GLOBE NEWSWIRE) -- BNB Network Company (Nasdaq: BNC), the treasury management business of CEA Industries Inc., today announced another major milestone in its treasury strategy, with total holdings now reaching 325,000 BNB, …
Genius Group Provides Update on Legal Cases
SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, has scheduled a Live Spaces call on X.com at 9.00am Eastern Time, August 26, 2025 …
Journey Medical Corporation to Present at the Emerging Growth Conference
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company primarily focused on selling and marketing FDA-approved …
Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
August 18, 2025 Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Opportunity to be First Mover in $7.3Bn Addressable Market Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), ( …
HeartCore’s Go IPO Client, rYojbaba Co., Ltd., Begins Trading on the Nasdaq Stock Market
NEW YORK and TOKYO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced its Go IPO client, rYojbaba Co., Ltd. …
Advent Technologies and Stralis announce Pioneering Relationship to Advance Hydrogen Electric Flight
LIVERMORE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) an innovation-driven leader in the fuel cell and hydrogen technology sector, is supplying its proprietary membrane electrode assembly technology to …
Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy
ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its new …
Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been promoted to Chief Financial Officer, effective August 16, …
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. patent No. 12,357,584 B2 entitled “Composition and Method of Controlling Infectious Diseases with …
VivoPower’s Tembo e-LV Subsidiary on Track for $200 Million Enterprise Value Investment from Energi Holdings via SPAC Transaction
Energi to acquire 51% of Tembo with VivoPower continuing to hold a significant shareholding in Tembo post-SPAC merger Energi is supportive of Tembo’s business combination with Cactus Acquisition Corp 1 Limited (“SPAC”) at an equity valuation of $838 …
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
NRx Drug Development Grant of expanded Fast Track Designation for NRX-100 from the FDA for all indications and types of depression and related disorders based on its potential to satisfy an unmet medical need. Represents an approximately 10-fold expansion …
Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
· Collaboration strengthens Boehringer’s pipeline in Eye Health. · Many patients with diabetic retinopathy (DR) continue to experience vision loss or treatment fatigue, underscoring an unmet need. · Melanocortin receptor agonists offer …